chr9-130693880-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_014285.7(EXOSC2):c.89G>T(p.Gly30Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,611,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014285.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC2 | NM_014285.7 | c.89G>T | p.Gly30Val | missense_variant | 1/9 | ENST00000372358.10 | NP_055100.2 | |
EXOSC2 | NM_001282708.1 | c.89G>T | p.Gly30Val | missense_variant | 1/8 | NP_001269637.1 | ||
EXOSC2 | NM_001282709.1 | c.89G>T | p.Gly30Val | missense_variant | 1/8 | NP_001269638.1 | ||
EXOSC2 | NR_104230.1 | n.121G>T | non_coding_transcript_exon_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC2 | ENST00000372358.10 | c.89G>T | p.Gly30Val | missense_variant | 1/9 | 1 | NM_014285.7 | ENSP00000361433.5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250596Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135560
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1459900Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 726252
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74296
ClinVar
Submissions by phenotype
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | DASA | Jan 05, 2022 | The c.89G>T;p.(Gly30Val) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 446202; OMIM: 602238.0001; PMID: 26843489) - PS4.The variant was observed to have arisen de novo (paternity confirmed) in a patient with the disease and no family history (PMID: 26843489) - PS2.The variant is present at low allele frequencies population databases (rs537467155– gnomAD 0.0005261%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Gly30Val) was detected in trans with a pathogenic variant (PMID: 26843489) - PM3. The variant co-segregated with disease in multiple affected family members (PMID: 26843489) - PP1_moderate. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 02, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jun 28, 2024 | Criteria applied: PS3_SUP,PM2,PM3,PP3 - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | EXOSC2: PM2, PM3, PP3, PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 30 of the EXOSC2 protein (p.Gly30Val). This variant is present in population databases (rs537467155, gnomAD 0.004%). This missense change has been observed in individuals with EXOSC2-related conditions (PMID: 26843489). ClinVar contains an entry for this variant (Variation ID: 446202). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXOSC2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects EXOSC2 function (PMID: 31628467, 34162742). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at